Diagnosis and Lab Work: Understanding the Results
At a Glance
Doctors diagnose ehrlichiosis using routine blood tests showing low white blood cells, low platelets, and elevated liver enzymes, alongside specialized PCR or antibody tests. Crucially, treatment with doxycycline should start immediately based on symptoms, without waiting for final lab results.
Diagnosing ehrlichiosis is like solving a puzzle. Because early symptoms look like many other illnesses, your doctor relies on two different types of information: routine blood work (which shows how your body is reacting) and specialized tests (which look for the bacteria itself) [1][2].
The “Clues” in Your Routine Lab Work
Most patients with ehrlichiosis show a specific “triad” or group of three findings in their basic blood tests [1]. If you are looking at your own lab report, you may see these terms:
- Leukopenia (Low White Blood Cell Count): Your white blood cells are the body’s primary defenders. Because Ehrlichia bacteria infect and destroy these cells, your count often drops early in the illness [1][2].
- Thrombocytopenia (Low Platelets): Platelets help your blood clot. In ehrlichiosis, your platelet count often falls, which is a key signal to your doctor that a tick-borne illness might be present [1].
- Elevated Liver Enzymes (AST and ALT): These markers (transaminases) indicate that your liver is temporarily inflamed or stressed by the infection [2][3].
Specialized Diagnostic Tests
While routine labs suggest ehrlichiosis, specialized tests are needed to confirm it. There are two main types:
PCR (The “Early” Test)
PCR (Polymerase Chain Reaction) is the preferred test when you are currently sick [1][4].
- How it works: It searches for the actual DNA of the Ehrlichia bacteria in your blood [5].
- When to use it: It is most accurate during the first week of symptoms, when the bacteria are circulating in your bloodstream [1].
IFA or Serology (The “Antibody” Test)
IFA (Indirect Fluorescent Antibody) tests look for antibodies, which are proteins your immune system creates to fight the infection [6].
- The Problem with Timing: Your body takes time to build these antibodies—usually 7 to 10 days or longer [1][7].
- The “Window Period”: If you take an IFA test too early, it will likely come back negative even if you are truly infected [8]. This is why doctors often perform a second “convalescent” test 2 to 4 weeks later to see if your antibody levels have risen [6][9].
Follow-up Lab Timing
Your doctor will likely want to repeat your routine blood work to ensure your body is recovering. Most patients have their CBC (for platelets/white blood cells) and liver enzymes re-checked 1 to 2 weeks after finishing antibiotics to confirm everything has returned to a safe baseline [10].
The Golden Rule: Treat First, Test Later
The most important thing for you and your caregivers to know is that doctors should not wait for test results to start treatment [7][11].
Because both PCR and IFA tests can take days to return, and because a “negative” test in the first few days doesn’t always mean you are healthy, current medical guidelines recommend starting doxycycline immediately if your symptoms and routine labs suggest ehrlichiosis [7][12]. Delaying treatment while waiting for a “definitive” result is a major risk factor for developing severe complications [7][13].
Note: If you have already started doxycycline, a PCR test may come back negative because the medication works so quickly to clear the bacteria from your blood [1]. This does not mean you didn’t have the infection; it just means the treatment is doing its job.
Common questions in this guide
Why are my white blood cell and platelet counts low?
Should I wait for my PCR or IFA test results before starting treatment?
What is the difference between a PCR and an IFA test for ehrlichiosis?
Why did my initial ehrlichiosis antibody test come back negative?
When should I re-check my lab work after having ehrlichiosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.My white blood cell count is low—is this 'leukopenia' common in the first week of Ehrlichiosis?
- 2.Does the PCR test I just had look for the actual DNA of the bacteria, or for my immune response?
- 3.Since we are still waiting on test results, can we start the doxycycline now to be safe?
- 4.If my initial antibody test (IFA) comes back negative, will we need to do a second 'convalescent' test in a few weeks to be sure?
- 5.When should we re-check my lab work to ensure my liver enzymes and platelets are returning to normal?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (13)
- 1
Human monocytotropic ehrlichiosis-A systematic review and analysis of the literature.
Gygax L, Schudel S, Kositz C, et al.
PLoS neglected tropical diseases 2024; (18(8)):e0012377 doi:10.1371/journal.pntd.0012377.
PMID: 39093857 - 2
Becoming Endemic: Anaplasmosis Imported Across State Borders.
Abraham JD, Wenning HS, Saeed DA, et al.
Cureus 2024; (16(4)):e57902 doi:10.7759/cureus.57902.
PMID: 38725788 - 3
Atypical presentation of human ehrlichiosis and anaplasmosis in children in Israel.
Raibin K, Levy I, Atiya Nasagi Y, et al.
Acta paediatrica (Oslo, Norway : 1992) 2019; (108(9)):1727-1728 doi:10.1111/apa.14882.
PMID: 31140643 - 4
Development and Clinical Validation of a Multiplex Real-Time Quantitative PCR Assay for Human Infection by Anaplasma phagocytophilum and Ehrlichia chaffeensis.
Reller ME, Dumler JS
Tropical medicine and infectious disease 2018; (3(1)) doi:10.3390/tropicalmed3010014.
PMID: 30274412 - 5
Targeted Metagenomics for Clinical Detection and Discovery of Bacterial Tick-Borne Pathogens.
Kingry L, Sheldon S, Oatman S, et al.
Journal of clinical microbiology 2020; (58(11)) doi:10.1128/JCM.00147-20.
PMID: 32878950 - 6
"Leopards do not change their spots:" tick borne disease symptomology case report.
Abernathy H, Alejo A, Arahirwa V, et al.
BMC infectious diseases 2022; (22(1)):699 doi:10.1186/s12879-022-07683-x.
PMID: 35986240 - 7
Assessment of Risk Factors and Outcomes of Severe Ehrlichiosis Infection.
Kuriakose K, Pettit AC, Schmitz J, et al.
JAMA network open 2020; (3(11)):e2025577 doi:10.1001/jamanetworkopen.2020.25577.
PMID: 33201233 - 8
Ehrlichiosis infection mimicking thrombotic microangiopathy syndrome early after kidney transplantation.
Hassan W, Talwar M, Balaraman V, Molnar MZ
Transplant infectious disease : an official journal of the Transplantation Society 2020; (22(5)):e13305 doi:10.1111/tid.13305.
PMID: 32358827 - 9
[Effectivity of diagnostic methods for the detection of human and canine monocytic ehrlichiosis].
Franco-Zetina M, Adame-Gallegos J, Dzul-Rosado K
Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 2019; (36(5)):650-655 doi:10.4067/S0716-10182019000500650.
PMID: 31859807 - 10
Myocarditis Secondary to Human Monocytotrophic Ehrlichiosis.
Kariyawasam V, Shah K
Cureus 2024; (16(4)):e59369 doi:10.7759/cureus.59369.
PMID: 38817458 - 11
Development and validation of real-time PCR assays for the detection of Ehrlichia species and E. chaffeensis in clinical specimens.
Chung IH, Austin AL, Kato CY
Journal of microbiological methods 2021; (186()):106225 doi:10.1016/j.mimet.2021.106225.
PMID: 33872636 - 12
Ehrlichiosis-Associated Hemophagocytic Lymphohistiocytosis: A Case Series and Review of the Literature.
Hammoud K, Fulmer R, Hamner M, El Atrouni W
Case reports in hematology 2023; (2023()):5521274 doi:10.1155/2023/5521274.
PMID: 36846547 - 13
Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichia Chaffeensis in Adults: A Case Series From Oklahoma.
Agudelo Higuita NI, Yuen C
The American journal of the medical sciences 2021; (361(2)):269-273 doi:10.1016/j.amjms.2020.08.029.
PMID: 32928497
This page explains ehrlichiosis diagnostic tests and lab results for educational purposes only. Always consult your healthcare provider or infectious disease specialist to interpret your specific laboratory reports and guide your treatment.
Get notified when new evidence is published on Ehrlichiosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.